Fentanyls are the synthetic psychoactive compounds which are 10000 times more potent than morphine. They have become a serious public health threat in recent years.
Synthetic opioids are highly addictive and, because of their potency, often prove fatal: among the roughly 72,000 drug overdose deaths in the US in 2017, some 30,000 were related to synthetic opioids.
Overdose Epidemic from Illegally Made Fentanyl in US
Substantial increases in fatal synthetic opioid involved overdoses, primarily driven by fentanyl-involved overdose deaths in multiple states since 2013.
Advertisement
‘New opioid vaccine offers hope to protect people from becoming drug addicts and over exposure’
Read More..
Tweet it Now
Read More..
But researchers at The Scripps Research Institute have created monoclonal antibodies--made by identical immune cells--that are effective against several synthetic opioids, including fentanyl and the deadliest of the fentanyls, carfentanil. Their findings could both combat opioid addiction as well as reduce overdose deaths.
The study looked at the efficacy of vaccines containing the newly developed opioid antibodies in animals. The team, led by Kim Janda, tested the antibodies using a common pain response challenge, in which a heated beam of light is applied to a mouse's tail.
The time it takes for the mouse to withdraw its tail is measured: quick reactions suggest the animal is feeling pain, whereas a longer response suggests that pain response has been muted.
Mice that were given opioids such as fentanyl or carfentanil without the antibody exhibited a big reduction in tail withdrawal, suggesting they could not sense the pain. When they were given the opioid-blocking antibody, tail withdrawal was normalized, suggesting that the vaccine blocked the analgesic effects of the drug.
The researchers then tested whether the vaccine could prevent against lethal overdose. In mice administered the vaccine followed by a dose of fentanyl that was fatal in non-vaccinated animals. All the vaccinated mice were protected from overdose.
The antibodies were also effective against other forms of fentanyl, including carfentanil and seven other analogs, in both pain tests and lethality studies.
Janda's team has begun to develop human antibodies to synthetic opioids, and will test their efficacy in the future.
"When it comes to the very powerful opioid carfentanil the current treatment for this opioid's induced lethality does not work very well--it has no staying power," says Janda. "Antibodies persist longer, and thus have enormous promise for addressing both opioid addiction as well as overdose."
A synthetic opioid vaccine might also be used as a prophylactic measure to protect people at risk of coming into contact with the drugs, such as first responders, who have occasionally overdosed by inhaling tiny quantities of fentanyl.
"These antibodies could be used to protect police, EMTs, and other first responders from inadvertent acute fentanyl exposure," says Janda. "A canine version might even one day be used to protect drug-sniffing dogs."
Source: Eurekalert
Advertisement
The time it takes for the mouse to withdraw its tail is measured: quick reactions suggest the animal is feeling pain, whereas a longer response suggests that pain response has been muted.
Mice that were given opioids such as fentanyl or carfentanil without the antibody exhibited a big reduction in tail withdrawal, suggesting they could not sense the pain. When they were given the opioid-blocking antibody, tail withdrawal was normalized, suggesting that the vaccine blocked the analgesic effects of the drug.
The researchers then tested whether the vaccine could prevent against lethal overdose. In mice administered the vaccine followed by a dose of fentanyl that was fatal in non-vaccinated animals. All the vaccinated mice were protected from overdose.
The antibodies were also effective against other forms of fentanyl, including carfentanil and seven other analogs, in both pain tests and lethality studies.
Janda's team has begun to develop human antibodies to synthetic opioids, and will test their efficacy in the future.
"When it comes to the very powerful opioid carfentanil the current treatment for this opioid's induced lethality does not work very well--it has no staying power," says Janda. "Antibodies persist longer, and thus have enormous promise for addressing both opioid addiction as well as overdose."
A synthetic opioid vaccine might also be used as a prophylactic measure to protect people at risk of coming into contact with the drugs, such as first responders, who have occasionally overdosed by inhaling tiny quantities of fentanyl.
"These antibodies could be used to protect police, EMTs, and other first responders from inadvertent acute fentanyl exposure," says Janda. "A canine version might even one day be used to protect drug-sniffing dogs."
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Alcohol & Drug Abuse News
A new study analyses Whether treatment support can optimize nicotine replacement therapy to quit smoking faster, using biomarker nicotine metabolite ratio.
The genetic risk scores developed was found to be helpful in preventing and treating alcohol addiction.
The percentage of caregivers prescribing buprenorphine increased faster after the Medicaid reforms implementation.
New study examined whether metabolic syndrome could be a reason for increased mortality from alcohol-associated liver disease (ALD) despite declining alcohol use.
Addiction scientists try to decode cocaine use disorder.